Puberty and Body CompositionNCT02908971
Association Between Soy Based Formula in Infancy and Puberty
An observational study of Puberty and Body Composition, run by Assaf-Harofeh Medical Center at 1 site in Israel.
Trial summary
Background: Children in industrialized and developing countries have a higher tendency to present earlier signs of puberty. One hypothesis includes the hormonal effects of phytoestrogens found in soy products. Read more about this study
- Who is it for?
- Ages 6 to 12 yearsHealthy volunteers can take part
- Conditions the study is for
- Puberty and Body Composition
- What is being tested?
- soy based formula at infancy
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 98 participants
- Where
- 1 siteIsrael
- Study dates
- 1 May 2013to May 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 12 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: The study population is based on a large cohort study initiated and performed during 2004-2006 by Katz Y et al , which followed prospectively all newborns born during this time period at Assaf Haroffeh Medical Center, Zerifin, Israel . The study looked into their nutritional intake, development of sensitivity to milk and milk allergies. The population included a total of 13019 children, out of which 66 developed an IgE-mediated Cow Milk Allergy (CMA), 71 developed milk-sensitivity, and 12638 were healthy. Our study population included all CMA group and a randomized group from the healthy population (nested cohort).
Inclusion Criteria: All participants of initial cohort of children born 2004-2006 -
Exclusion Criteria: Those from soy group who did not consume soy based formula. Those from healthy control who did consume soy formula.
Refusal for physical examination.
-
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Association Between Soy Based Formula Consumption During Infancy and the Timing of Pubertal Signs and BMI-SDS
Background: Children in industrialized and developing countries have a higher tendency to present earlier signs of puberty. One hypothesis includes the hormonal effects of phytoestrogens found in soy products.
Objective: to examine the association between consumption of soy-based food in early infancy and childhood and the incidence of early or precocious puberty and overweight in school-aged children.
Methods: the study population for this case control study is randomized from a prospectively followed cohort of all babies born at Assaf Haroffeh medical center and followed for milk allergy signs and food intake until the age of 3 years (A nested cohort). It is divided to those who were allergic to milk, and thus consumed only soy based formula and food during infancy and childhood (soy group) and a randomized control group who consumed non-soy based intake. For both groups data are available of food habits during infancy and collected from 3 days food diaries during the current study. Physical examination, including weight , height, blood pressure and Tanner Pubertal Staging will performed annually.
Read the detailed description
Soy and soy-based products are widely used in modern day nutrition. It is widely consumed among all populations, especially among vegetarians, vegans, those with milk allergy, and in the general population who consume processed foods .Soy-based infant formula is commonly used, and may account for nearly 25 % of the infant formula sold . Soy products contain phytoestrogens (isoflavones) that were suggested to function as weak hormonal disruptors due to their functional similarity to mammalian estrogens and their active metabolites. Studies regarding the effects of soy consumption on pediatric growth and body mass have been inconclusive. Infants who are fed soy-based formulas have higher isoflavones blood concentration compared to breast-fed and milk-based formulas fed babies . Several studies discuss its effect on infantile physiologic telarche . Several retrospective, case-control and case studies were reported trying to elucidate the possible clinical association between consumption of soy products during infancy and childhood and pubertal and menarchal timing. However, there results are contradictory and inconclusive .Furthermore, in some of the studies there is no discussion of the association or confounding effect of overweight which is also associated with pubertal timing. Despite the importance of the topic, there is paucity of prospective data regarding the impact of soy based products consumption on puberty and body mass index (BMI).
Thus, this prospective study will examine the relationship between the consumption of soy- based formulas in early infancy with the development of early puberty and changes in anthropometric measures in school-aged children. The goal of this study is to test the association between early consumption of soy based formula and the timing of onset of secondary sexual characteristics in a prospective mannor and with consideration of current dietary intake and confounding factors as BMI and familial trends.
MATERIALS AND METHODS Study Population The study population is based on a large cohort study initiated and performed during 2004-2006 by Katz Y et al ,which followed prospectively all newborns born during this time period at Assaf Haroffeh Medical Center, Zerifin, Israel.The study looked into their nutritional intake, development of sensitivity to milk and milk allergies. The population included a total of 13019 children, out of which 66 developed an IgE-mediated Cow Milk Allergy (CMA), 71 developed milk-sensitivity, and 12638 were healthy. Our study population includes all CMA group and a randomized group from the healthy population (nested cohort).
Inclusion criteria : all participants from initial study . Exclusion criteria:lack of data regarding food intake during infancy in both groups. In the non-allergic children, from the non soy based group those who consumed soy - based formula for religious or ideological reasons will be excluded.
Study design This is a case-control study, including a specific sub-population from a large cohort population including prospectively collected data on infantile food consumption. All original cohort participants, who fulfill the inclusion criteria will be approached for participation in the current study. The current study will include demographic and clinical data collection, an interview and 3 days of food diary preparation and dietician analysis and a physical examination by a pediatric Endocrinologist.
Demographic and clinical data Collection Data will include the information from the initial prospective follow up at infancy including birth weight, birth week, parental origin, infantile food habits, maternal age and allergy classification. Data collected at the current session: family health history including obesity, early or delayed puberty, ,age of maternal menarche and age of paternal shaving, parental height. The child physical activity levels and nutritional habits, illnesses, medications . Height and weight were measured and body mass index [BMI] will calculated and reported as BMI-SDS . Tanner score was used to characterize sexual maturation. The pre-pubertal state was defined as Tanner stage 1 genitalia and testicular volume ≤3 ml in boys and absence of breast development in girls. A specific description of axillary odor and axillary hair and pubertal hair will be performed for adrenarche signs.
Dietary intake analysis All participants will fill a detailed 3 days food diary (two weekdays and one weekend day) according to guidance by the study dietician. The nutritional data from the food records will be analyzed using the Tzameret Program (or A computer program, based on local food tables, developed by Israeli ministry of Health) ).Results of the analysis will be reported as percent-Dietary Reference Intakes (DRI).
- Conditions
- Puberty and Body Composition
- Being tested
- soy based formula at infancy
- Keywords
- soy based formula, overweight, adrenarche,, gonadarache
- Medical subject headings
- Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
soy based formula at infancyBehavioural
The intervention is only past history of soy consumption
| Study group | Role | What they receive |
|---|---|---|
| Soy based formula | "soy group" will include children from the children who had milk allergy, and consumed a soy-based substitute formula for longer than three months and agreed to participate in this study. Receives: Behavioral: soy based formula at infancy | |
| Healthy control | The control group will included children (at a rate of 2:1) who will be assigned randomly from the healthy population at the initial cohort, and who will agree to participate. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Age of adrenarche signs
Age of adrenarche signs will be compared between soy and control groups
Measured: 5 years
Age of gonadarche signs
Age of gonadarche signs will be compared between soy and control groups
Measured: 5 years
Secondary outcomes (1)
comparison of rate of Overweight and obesity
BMI-SDS will be compared between groups
Measured: 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2016 (estimated)
- Study start1 May 2013
- Primary completionMay 2020
- Study completionMay 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Puberty and Body CompositionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 98 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assaf-Harofeh Medical Center
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Assaf Harofeh MC, Assaf-Harofeh Medical Center
- Investigators
- Marianna Rachmiel, MD, Principal investigator, Assaf Haroffeh Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02908971
- Sponsor's protocol ID
- 257/15
- Status last verified
- May 2020
- First submitted
- 18 Sep 2016
- Last updated
- 26 May 2020
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Association Between Soy Based Formula Consumption During Infancy and the Timing of Pubertal Signs and BMI-SDS
- ClinicalTrials.gov ID
- NCT02908971
- Acronym / sponsor ID
- 257/15
- Conditions
- Puberty and Body Composition
- Keywords
- soy based formula, overweight, adrenarche,, gonadarache
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 98 participants (actual)
- Lead sponsor
- Assaf-Harofeh Medical CenterOther government
- Study start
- 1 May 2013 (actual)
- Primary completion
- May 2020 (actual)
- Study completion
- May 2020 (actual)
- First posted
- 21 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Children in industrialized and developing countries have a higher tendency to present earlier signs of puberty. One hypothesis includes the hormonal effects of phytoestrogens found in soy products.
Objective: to examine the association between consumption of soy-based food in early infancy and childhood and the incidence of early or precocious puberty and overweight in school-aged children.
Methods: the study population for this case control study is randomized from a prospectively followed cohort of all babies born at Assaf Haroffeh medical center and followed for milk allergy signs and food intake until the age of 3 years (A nested cohort). It is divided to those who were allergic to milk, and thus consumed only soy based formula and food during infancy and childhood (soy group) and a randomized control group who consumed non-soy based intake. For both groups data are available of food habits during infancy and collected from 3 days food diaries during the current study. Physical examination, including weight , height, blood pressure and Tanner Pubertal Staging will performed annually.
Detailed description
Soy and soy-based products are widely used in modern day nutrition. It is widely consumed among all populations, especially among vegetarians, vegans, those with milk allergy, and in the general population who consume processed foods .Soy-based infant formula is commonly used, and may account for nearly 25 % of the infant formula sold . Soy products contain phytoestrogens (isoflavones) that were suggested to function as weak hormonal disruptors due to their functional similarity to mammalian estrogens and their active metabolites. Studies regarding the effects of soy consumption on pediatric growth and body mass have been inconclusive. Infants who are fed soy-based formulas have higher isoflavones blood concentration compared to breast-fed and milk-based formulas fed babies . Several studies discuss its effect on infantile physiologic telarche . Several retrospective, case-control and case studies were reported trying to elucidate the possible clinical association between consumption of soy products during infancy and childhood and pubertal and menarchal timing. However, there results are contradictory and inconclusive .Furthermore, in some of the studies there is no discussion of the association or confounding effect of overweight which is also associated with pubertal timing. Despite the importance of the topic, there is paucity of prospective data regarding the impact of soy based products consumption on puberty and body mass index (BMI).
Thus, this prospective study will examine the relationship between the consumption of soy- based formulas in early infancy with the development of early puberty and changes in anthropometric measures in school-aged children. The goal of this study is to test the association between early consumption of soy based formula and the timing of onset of secondary sexual characteristics in a prospective mannor and with consideration of current dietary intake and confounding factors as BMI and familial trends.
MATERIALS AND METHODS Study Population The study population is based on a large cohort study initiated and performed during 2004-2006 by Katz Y et al ,which followed prospectively all newborns born during this time period at Assaf Haroffeh Medical Center, Zerifin, Israel.The study looked into their nutritional intake, development of sensitivity to milk and milk allergies. The population included a total of 13019 children, out of which 66 developed an IgE-mediated Cow Milk Allergy (CMA), 71 developed milk-sensitivity, and 12638 were healthy. Our study population includes all CMA group and a randomized group from the healthy population (nested cohort).
Inclusion criteria : all participants from initial study . Exclusion criteria:lack of data regarding food intake during infancy in both groups. In the non-allergic children, from the non soy based group those who consumed soy - based formula for religious or ideological reasons will be excluded.
Study design This is a case-control study, including a specific sub-population from a large cohort population including prospectively collected data on infantile food consumption. All original cohort participants, who fulfill the inclusion criteria will be approached for participation in the current study. The current study will include demographic and clinical data collection, an interview and 3 days of food diary preparation and dietician analysis and a physical examination by a pediatric Endocrinologist.
Demographic and clinical data Collection Data will include the information from the initial prospective follow up at infancy including birth weight, birth week, parental origin, infantile food habits, maternal age and allergy classification. Data collected at the current session: family health history including obesity, early or delayed puberty, ,age of maternal menarche and age of paternal shaving, parental height. The child physical activity levels and nutritional habits, illnesses, medications . Height and weight were measured and body mass index [BMI] will calculated and reported as BMI-SDS . Tanner score was used to characterize sexual maturation. The pre-pubertal state was defined as Tanner stage 1 genitalia and testicular volume ≤3 ml in boys and absence of breast development in girls. A specific description of axillary odor and axillary hair and pubertal hair will be performed for adrenarche signs.
Dietary intake analysis All participants will fill a detailed 3 days food diary (two weekdays and one weekend day) according to guidance by the study dietician. The nutritional data from the food records will be analyzed using the Tzameret Program (or A computer program, based on local food tables, developed by Israeli ministry of Health) ).Results of the analysis will be reported as percent-Dietary Reference Intakes (DRI).
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Soy based formula | – | Behavioral: soy based formula at infancy"soy group" will include children from the children who had milk allergy, and consumed a soy-based substitute formula for longer than three months and agreed to participate in this study. |
| Healthy control | – | –The control group will included children (at a rate of 2:1) who will be assigned randomly from the healthy population at the initial cohort, and who will agree to participate. |
Who may qualify
- Ages
- 6 to 12 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- The study population is based on a large cohort study initiated and performed during 2004-2006 by Katz Y et al , which followed prospectively all newborns born during this time period at Assaf Haroffeh Medical Center, Zerifin, Israel . The study looked into their nutritional intake, development of sensitivity to milk and milk allergies. The population included a total of 13019 children, out of which 66 developed an IgE-mediated Cow Milk Allergy (CMA), 71 developed milk-sensitivity, and 12638 were healthy. Our study population included all CMA group and a randomized group from the healthy population (nested cohort).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| soy based formula at infancyThe intervention is only past history of soy consumption | Behavioural | Soy based formula |
Primary outcome
Age of adrenarche signs
Time frame: 5 years
Age of adrenarche signs will be compared between soy and control groups
Age of gonadarche signs
Time frame: 5 years
Age of gonadarche signs will be compared between soy and control groups
1 secondary outcome
comparison of rate of Overweight and obesity
Time frame: 5 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2020.
- Individual participant dataSharing planned: No
Related trials for Puberty and Body Composition
RecruitingPhase 4
Klinefelter Syndrome and Testosterone Treatment in Puberty
Klinefelter Syndrome
Enrolling by invitationObservational study
Skeletal Maturation and Endocrine Health in Young Adults
Osteoporosis, Sarcopenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marianna Rachmiel, MD principal investigator
Assaf Haroffeh Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Puberty and Body Composition, run by Assaf-Harofeh Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Age of adrenarche signs (time frame: 5 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2020.